Evidence map›Paper›PMID 42477297›Full record

ReviewHormones (Athens, Greece)2026

EndoBridge 2025: pearls and highlights.

Bulent Okan Yildiz, Mirco Armenti, Maria Luisa Brandi, John Carey, Tobias Carling, Andreea Ciudin, Ketan Dhatariya, Athanasios Fountas, Gema Frühbeck, Dimitrios Goulis and 23 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Bulent Okan YildizDivision of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Hacettepe, Ankara, 06100, Türkiye. yildizbo@yahoo.com.ORCID http://orcid.org/0000-0003-1797-7662
Mirco ArmentiGraves' Orbitopathy Center, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Maria Luisa BrandiFIRMO Foundation, Italy and McMaster University, Hamilton, Canada.
John CareyClinical Sciences Institute, University of Galway, Galway, Ireland.
Tobias CarlingHospital for Endocrine Surgery Research Center, HCA Florida Healthcare, HCA Healthcare Research Institute, Tampa, Florida, USA.
Andreea CiudinEndocrinology and Nutrition Department, EASO COM, Barcelona, Spain.
Ketan DhatariyaElsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney Lane, Norwich, Norfolk, NR4 7UY, UK.
Athanasios FountasDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, IBR Tower, Level 2, Birmingham, B15 2TT, UK.
Gema FrühbeckDepartment of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, 31008, Spain.
Dimitrios GoulisUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Maria GrammatikopoulouDepartment of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece.
Mark GurnellInstitute of Metabolic Science, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.
Gary D HammerEndocrine Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
Angelica Lindén HirschbergDepartment of Women's and Children's Health, Department of Gynecology and Reproductive Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Susan JawadDepartment of Imaging, University College London Hospitals, London, UK.
Jacqueline JonklaasDivision of Endocrinology, Georgetown University, Washington, District of Columbia, USA.
Ursula KaiserDivision of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Niki KaravitakiDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, IBR Tower, Level 2, Birmingham, B15 2TT, UK.
Aliya KhanMcMaster University, Hamilton, ON, Canada.
Luka LezaicDivision of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
James MacFarlaneInstitute of Metabolic Science, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.
Djuro MacutDepartment for Neuroendocrine Tumors and Hereditary Cancer Syndromes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia.
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Barbara McGowanDiabetes and Endocrinology, Guy's and St Thomas Hospital and King's College London, London, UK.
Dipesh PatelRoyal Free London, University College London, London, UK.
Athena Philis-TsimikasScripps Whittier Diabetes Institute, San Diego, CA, USA.
Lena RadićDepartment for Neuroendocrine Tumors and Hereditary Cancer Syndromes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade, Serbia.
Mario SalviGraves' Orbitopathy Center, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Emily Rose N San DiegoScripps Whittier Diabetes Institute, San Diego, CA, USA.
Heide SiggelkowMVZ endokrinologikum Göttingen, Göttingen, Germany.
Constantine A StratakisHospital for Endocrine Surgery Research Center, HCA Florida Healthcare, HCA Healthcare Research Institute, Tampa, Florida, USA.
Dilek YaziciDivision of Endocrinology, Department of Internal Medicine, School of Medicine, Koç University, İstanbul, Türkiye.
Ozlem CelikDivision of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Acibadem University, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 13th Annual EndoBridge Meeting took place in Antalya, Türkiye, from October 23 to 26, 2025. Accredited by the European Council, the congress delivered a comprehensive scientific program combining state-of-the-art lectures with interactive small-group case discussions led by internationally recognized experts in endocrinology and metabolism. The meeting drew a diverse audience and provided an in-depth review of major areas within the field. Core subjects included disorders of the pituitary, thyroid, adrenal glands, and bone metabolism, as well as neuroendocrine tumors, diabetes, obesity, clinical nutrition, and lipid abnormalities. Clinical case abstracts presented in oral and poster sessions were subsequently published in JCEM Case Reports. This report highlights the principal themes and clinical insights shared during the congress. Key discussions addressed contemporary approaches to acromegaly management, therapeutic strategies for subclinical thyroid dysfunction, goal-oriented treatment models in osteoporosis, adjunctive options in type 1 diabetes management, and the evolving concept of obesity phenotyping. Additional updates covered hormonal treatment strategies for menopause and premature ovarian insufficiency, along with recent developments in male hypogonadism and infertility. Overall, the sessions reflected current advances in endocrine science while offering practical guidance for the management of common and complex endocrine disorders. The 14th Annual EndoBridge Meeting will be held in Antalya, Türkiye, from October 22 to 25, 2026.

Indexed as

AdrenalBoneDiabetes mellitusObesityPituitaryThyroid

Identifiers

PMID42477297

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.